Literature DB >> 2837512

I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif.

A Sette1, S Buus, S Colon, C Miles, H M Grey.   

Abstract

Purified Ia molecules can specifically bind many unrelated peptide Ag, and such binding appears to be a necessary, albeit not sufficient, prerequisite for the immunogenicity of the proteins from which such peptides are derived. We have recently analyzed the affect of single amino acid substitutions on the I-Ad binding of the immunogenic peptide OVA 323-339. The results obtained demonstrated the very permissive nature of Ag-Ia interaction. We also showed that unrelated peptides that are good I-Ad binders share a common structural motif and speculated that recognition of such motifs could represent a mechanism to achieve a very permissive type of interaction that yet retained some degree of specificity. In the present set of experiments we analyzed the I-Ad binding pattern of a series of overlapping peptides derived from sperm whale myoglobin (residues 102-125) and influenza hemagglutinin (residues 121-146) to determine whether the peptide regions predicted on the basis of structural similarity to be involved in I-Ad binding were in fact involved. In both cases, the I-Ad-interacting determinants were found to contain the sequence motif postulated to be important for I-Ad binding. These data support the hypothesis that I-Ad molecules recognize a large library of Ag by virtue of common structural motifs present in peptides derived from phylogenetically unrelated proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition.

Authors:  Anish Suri; James J Walters; Osami Kanagawa; Michael L Gross; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 2.  Human cartilage proteoglycans as T cell autoantigens.

Authors:  J A Goodacre; J P Pearson
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

Review 3.  A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease.

Authors:  D C Wraith; D E Smilek
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.

Authors:  C V Harding; E R Unanue
Journal:  Cell Regul       Date:  1990-06

5.  Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase).

Authors:  Kirk D C Jensen; Eli E Sercarz; Claudia Raja Gabaglia
Journal:  Mol Immunol       Date:  2008-11-29       Impact factor: 4.407

Review 6.  Peptide presentation by class-I major histocompatibility complex molecules.

Authors:  J Nikolić-Zugić; F R Carbone
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus.

Authors:  C J Hackett; D Horowitz; M Wysocka; L C Eisenlohr
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 8.  Structural requirements for the interaction between class II MHC molecules and peptide antigens.

Authors:  A Sette; S Buus; E Appella; L Adorini; H M Grey
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

9.  Modelling of peptide and protein structures.

Authors:  S Fraga; J M Parker
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

Review 10.  Drug delivery issues in vaccine development.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.